NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark K. OkiChief Financial Officer2025-03-1710,000$2.89
$28.89kBuy
Richard Alistair StewartChieve Executive Officer2025-03-1710,000$2.86
$28.60kBuy

1 of 1

ACHV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Propel Bio Management LLC17.74%6,153,091$15.69MInstitution
Franklin Resources Inc12.86%4,459,014$11.37MInstitution
Dialectic Capital Management LP10.23%3,549,000$9.05MInsider
Alyeska Investment Group LP10.10%3,504,333$8.94MInstitution
Vanguard Group Inc6.20%2,149,877$5.48MInstitution
Robert Schacter5.27%1,827,426$4.66MInsider
Armistice Capital LLC4.59%1,593,188$4.06MInsider
Clearline Capital LP3.82%1,326,259$3.38MInstitution
Simplify Asset Management Inc3.42%1,184,512$3.02MInstitution
Hudson Bay Capital Management LP3.38%1,173,532$2.99MInstitution

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV73.26%26.74%Net Buying
CRVO3.08%96.92%Net Buying
CSBR1.96%98.04%Net Buying
NAUT39.18%60.82%Net BuyingNet Buying
CABA94.51%5.49%

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 75.61% institutional shareholders, 27.59% Achieve Life Sciences insiders, and 0.00% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 10.23% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $9.05M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.